Bupropion Hydrochloride Tablet, Extended Release
Product Images NDC 71205-291

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Bupropion Hydrochloride (NDC 71205-291). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Proficient Rx Lp, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

71205-291-90 (150mg 500ct)

71205-291-90 (150mg 500ct)
This is a description of Bupropion HCI 150mg (Once Daily) medication in the form of #30 XL Tablets. This medication guide is required to be dispensed separately to each patient. The extended-release tablets contain 150mg bupropion hydrochloride, USP. It is manufactured by CSPC Ouyi Pharmaceutical Co., Ltd. in China and packaged by Proficient Rx LP, Thousand Oaks, CA. This medication should not be used in combination with ZYBAN or any other medicines that contain bupropion hydrochloride. The tablets have "150 XL" imprinted on one side in black ink and are blank on the other side. The NDC number is 71205-291-30, and the lot and expiration dates are 00000 and 00/00/00, respectively.*
FDA Label Image

Structural-formula (Structural Formula)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.